Matthew J Gallek
Overview
Explore the profile of Matthew J Gallek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gallegos J, Taylor-Piliae R, Pace T, Gallek M, Ritter L
SAGE Open Nurs
. 2024 Aug;
10:23779608241272513.
PMID: 39139192
Introduction: Filipino Americans (FAs) are at high risk for developing type 2 diabetes despite other Asian phenotypes. Evidence suggests that pro-inflammatory interleukin-18 (IL-18) and anti-inflammatory adiponectin biomarkers associated with visceral...
2.
McAteer A, Hravnak M, Chang Y, Crago E, Gallek M, Yousef K
Biol Res Nurs
. 2017 Jun;
19(5):531-537.
PMID: 28627225
Introduction: Neurocardiac injury, a type of myocardial dysfunction associated with neurological insult to the brain, occurs in 31-48% of aneurysmal subarachnoid hemorrhage (aSAH) patients. Cardiac troponin I (cTnI) is commonly...
3.
McCallum A, Gallek M, Ramey W, Manziello A, Witte M, Bernas M, et al.
Pathophysiology
. 2016 Jun;
23(3):181-90.
PMID: 27354343
Introduction: Despite being one of the most common neurological diseases, it is unknown whether there may be a genetic basis to temporal lobe epilepsy (TLE). Whole genome analyses were performed...
4.
Gallek M, Skoch J, Ansay T, Behbahani M, Mount D, Manziello A, et al.
Neurogenetics
. 2016 Jun;
17(4):211-218.
PMID: 27251580
Whole genome analyses were performed to test the hypothesis that temporal cortical gene expression differs between epilepsy patients rendered seizure-free versus non-seizure-free following anterior temporal lobectomy with amygdalohippocampectomy (ATL/AH). Twenty...
5.
Shaw K, Gallek M, Sheppard K, Ritter L, Vento M, Asai S, et al.
Hawaii J Med Public Health
. 2015 Jun;
74(6):203-9.
PMID: 26114075
Minorities are less likely to decide on withdrawal of life support (WOLS) after acute severe illness. However, the decision-making process for WOLS after intracerebral hemorrhage (ICH) among Native Hawaiians and...
6.
Haynes H, Gallek M, Sheppard K, Drake K, Ritter L
J Am Assoc Nurse Pract
. 2015 Mar;
27(10):558-67.
PMID: 25736191
Purpose: The purpose of this study was to identify elements of a stroke population that may affect transitions of care (TOC). Data Sources: A retrospective analysis of the demographic characteristics...
7.
Gallek M, Alexander S, Crago E, Sherwood P, Klamerus M, Horowitz M, et al.
Biol Res Nurs
. 2014 May;
17(2):185-90.
PMID: 24852947
Aneurysmal subarachnoid hemorrhage is a type of stroke with high morbidity and mortality. Increased endothelin-1 (ET-1) levels have been associated with increased risk of cerebral vasospasm, which is associated with...
8.
Wung S, Hickey K, Taylor J, Gallek M
J Nurs Scholarsh
. 2013 Feb;
45(1):60-8.
PMID: 23368089
Purpose: This article provides an update on cardiovascular genomics using three clinically relevant exemplars, including myocardial infarction (MI) and coronary artery disease (CAD), stroke, and sudden cardiac death (SCD). ORGANIZATIONAL...
9.
Gallek M, Ritter L
Annu Rev Nurs Res
. 2012 Aug;
29:205-26.
PMID: 22891506
In the past 25 years, remarkable progress has been made in our understanding of genomics and its influence on central nervous system diseases. In this chapter, common diseases of the...
10.
Thampatty B, Sherwood P, Gallek M, Crago E, Ren D, Hricik A, et al.
Neurocrit Care
. 2011 Feb;
15(1):19-27.
PMID: 21286855
Background: Endothelin-1 (ET-1) is a potent vasoconstrictor implicated in the pathogenesis of vasospasm and delayed cerebral ischemia (DCI) in aneurysmal subarachnoid hemorrhage (aSAH) patients. The aim of this study was...